Drug
SYR-472
SYR-472 is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Total Trials
7
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 7 completed trials
Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Phase Distribution
Ph phase_2
2
29%
Ph phase_3
4
57%
Ph phase_1
1
14%
Phase Distribution
1
Early Stage
2
Mid Stage
4
Late Stage
Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
4(57.1%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
7 of 7 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
7
all time
Status Distribution
Completed(7)
Detailed Status
Completed7
Development Timeline
Analytics
Development Status
Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 34 (57.1%)
Trials by Status
completed7100%
Recent Activity
0 active trials
Showing 5 of 7
completedphase_1
A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets
NCT02372097
completedphase_3
Long-term Study of SYR-472
NCT01431807
completedphase_3
A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
NCT02324569
completedphase_3
Double-blind Comparative Study of SYR-472
NCT01632007
completedphase_3
SYR-472 Open-label Study
NCT01751360
Clinical Trials (7)
Showing 7 of 7 trials
NCT02372097Phase 1
A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets
NCT01431807Phase 3
Long-term Study of SYR-472
NCT02324569Phase 3
A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
NCT01632007Phase 3
Double-blind Comparative Study of SYR-472
NCT01751360Phase 3
SYR-472 Open-label Study
NCT00653185Phase 2
Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus
NCT00760344Phase 2
Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7